Citi lowered the firm’s price target on Kimberly-Clark (KMB) to $118 from $125 and keeps a Sell rating on the shares as part of a Q4 earnings preview for the beverages, household and personal care sector. Currency headwinds on the dollar strength are likely to bring down 2025 earnings growth outlooks to low- to mid-single-digits for most names with international exposure, the analyst tells investors in a research note. Citi also expects a focus on potential implications from the incoming Trump administration on tariffs, immigration, product reformulations, and corporate taxes. Names the firm is positive on into the print include Coca-Cola (KO), Clorox (CLX), and Boston Beer (SAM), while it is cautious on Kenvue (KVUE), Monster Beverage (MNST), and Colgate-Palmolive (CL).
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KMB:
- Kimberly-Clark downgraded to Hold at TD Cowen on organic growth concerns
- Kimberly-Clark downgraded to Hold from Buy at TD Cowen
- Kimberly-Clark price target lowered to $161 from $175 at Piper Sandler
- Kimberly-Clark price target lowered to $140 from $143 at Deutsche Bank
- Costco changes manufacturer for Kirkland Signature diapers, Bloomberg says